Search | IOVS | ARVO Journals

Showing 1 – 20 of 92

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Increased expression of tristetraprolin dampens acquisition of immunity and development of pathology in experimental autoimmune uveitis

Biying Xu; Jihong Tang; Cancan Lyu; Wambui S Wandu; Deborah J Stumpo; Mary Mattapallil; Rachel Caspi; Perry J Blackshear; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3676. doi:

ARVO Annual Meeting Abstract July 2019

Laquinimod effectively inhibits development of EAU and its associated immune effector responses

Biying Xu; Xiuzhi Jia; Jihong Tang; Rachel R Caspi; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):792. doi:

ARVO Annual Meeting Abstract July 2018

Non-redundant requirement for CXCR3 signaling for effective treatment of eye-specific autoimmunity with type I IFNs

Jun Chen; Chunmei Li; Weiwei Wang; Zilin Chen; Ying Chen; Hongyan Zhou; Wai Po Chong; Igal Gery; Rachel R Caspi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2537. doi:

ARVO Annual Meeting Abstract June 2017

Interferon beta modulates immune-mediated retinal inflammation by impairing T-cell trafficking

Jun Chen; Weiwei Wang; Zilin Chen; Hongyan Zhou; Eric F Wawrousek; Igal Gery; Rachel R Caspi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):547. doi:

Letters to the Editor March 2017

Chronic, Systemic Interleukin-18 Does Not Promote Macular Degeneration or Choroidal Neovascularization

PDF

Scott W. Canna; Guangpu Shi; Igal Gery; H. Nida Sen
TAGS: choroidal neovascularization, interleukin-18, macular degeneration
Invest. Ophthalmol. Vis. Sci.. 2017; 58(3):1764-1765. doi: https://doi.org/10.1167/iovs.17-21697

Immunology and Microbiology March 2016

Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal Degeneration

PDF

Samuel J. H. Hinshaw; Osato Ogbeifun; Wambui S. Wandu; Cancan Lyu; Guangpu Shi; Yichao Li; Haohua Qian; Igal Gery
TAGS: digoxin, mice, retinal degeneration, uveitis
Invest. Ophthalmol. Vis. Sci.. 2016; 57(3):1441-1447. doi: https://doi.org/10.1167/iovs.15-19040

ARVO Annual Meeting Abstract June 2015

Th9-induced conjunctival inflammation: A new animal model for allergic conjunctivitis

Cuiyan Tan; Wambui Wandu; Samuel Hinshaw; Chi-Chao Chan; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5871. doi:

ARVO Annual Meeting Abstract June 2015

TMP778 Inhibits Induction of Experimental Autoimmune Uveitis and related immune responses

Samuel Hinshaw; Wambul (Sylvia) Wambul Wandu; Guangpu Shi; Jianfei Yang; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):851. doi:

Retinal Cell Biology March 2015

Inflammasomes Induced by 7-Ketocholesterol and Other Stimuli in RPE and in Bone Marrow–Derived Cells Differ Markedly in Their Production of IL-1β and IL-18

PDF

Guangpu Shi; Siqi Chen; Wambui S. Wandu; Osato Ogbeifun; Lindsey F. Nugent; Arvydas Maminishkis; Samuel J. H. Hinshaw; Ignacio R. Rodriguez; Igal Gery
TAGS: bone marrow, inflammasomes, interleukin-18, retinal pigment cell, cytokine
Invest. Ophthalmol. Vis. Sci.. 2015; 56(3):1658-1664. doi: https://doi.org/10.1167/iovs.14-14557

ARVO Annual Meeting Abstract April 2014

Leucine-rich repeat kinase 2 (LRRK2) deficiency diminishes the development of EAU

Sylvia Wandu; Guangpu Shi; Osato Ogbeifun; Lindsey Nugent; Huaibin Cai; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1866. doi:

ARVO Annual Meeting Abstract April 2014

Effects of digoxin on experimental autoimmune uveitis (EAU) development and the mouse retina

Samuel JH Hinshaw; Osato Ogbeifun; Guangpu Shi; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1869. doi:

Immunology and Microbiology November 2013

ITE, A Novel Endogenous Nontoxic Aryl Hydrocarbon Receptor Ligand, Efficiently Suppresses EAU and T-Cell–Mediated Immunity

PDF

Lindsey F. Nugent; Guangpu Shi; Barbara P. Vistica; Osato Ogbeifun; Samuel J. H. Hinshaw; Igal Gery
TAGS: aryl hydrocarbon receptor, cytokine, immune response, cell-mediated, interleukin-17, ligands, mice, foxp3 gene, antibodies, immune response, interleukin-10
Invest. Ophthalmol. Vis. Sci.. 2013; 54(12):7463-7469. doi: https://doi.org/10.1167/iovs.12-11479

ARVO Annual Meeting Abstract June 2013

7-Ketocholesterol Induces Interleukin(IL)-1 beta and IL-18 Production in RPE Cells via Activation of the Inflammasome

Guangpu Shi; Osato Ogbeifun; Lindsey Nugent; Ignacio Rodriguez; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):150. doi:

ARVO Annual Meeting Abstract June 2013

TL1A is a potent enhancer of IL-9 production and ocular immunopathogenicity by Th9 cells

Cuiyan Tan; Francoise Meylan; Barbara Vistica; Richard Siegel; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):354. doi:

ARVO Annual Meeting Abstract March 2012

A Novel Nontoxic Aryl Hydrocarbon Receptor Ligand, ITE, Suppresses Immune-mediated Ocular Inflammation

Lindsey F. Nugent; Guangpu Shi; Barbara P. Vistica; Cuiyan Tan; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2759. doi:

ARVO Annual Meeting Abstract March 2012

Cell-cell Interaction with APC, not IL-23, is Required for Naive CD4 Cells to Acquire Pathogenicity During Th17 Lineage Commitment

Guangpu Shi; Jenna D. Lovaas; Cuiyan Tan; Barbara P. Vistica; Eric F. Wawrousek; Mehak K. Aziz; Rachael C. Rigden; Rachel R. Caspi; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5487. doi:

ARVO Annual Meeting Abstract March 2012

DAP-12, a Major Immunomediator, Either Promotes or Suppresses EAU Development

Barbara P. Vistica; Vanessa Montalvo-Reddin; Guangpu Shi; Lindsey Nugent; Laura Quigley; Daniel W. McVicar; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6239. doi:

ARVO Annual Meeting Abstract April 2011

Acquisition of Th1, Th17, or Treg Phenotypes Differs Among CD4 T Cells in Ocular Inflammation Triggered by Different TLR Ligands

Guangpu Shi; Barbara P. Vistica; Lindsey F. Nugent; Eric F. Wawrousek; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2279. doi:

ARVO Annual Meeting Abstract April 2011

SLAT/Def6 Knock-Out (KO) Mice Exhibit Profoundly Reduced Capacity to Develop Experimental Autoimmune Uveitis (EAU)

Barbara P. Vistica; Guangpu Shi; Lindsey Nugent; Amnon Altman; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2926. doi:

ARVO Annual Meeting Abstract April 2011

Antigen-Specific Th9 Cells are Unique in their Cytokine Kinetics, Plasticity and Retention at the Inflammatory Site

Lindsey F. Nugent; Cuiyan Tan; Mehak Aziz; Barbara P. Vistica; Guangpu Shi; Igal Gery

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3011. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Increased expression of tristetraprolin dampens acquisition of immunity and development of pathology in experimental autoimmune uveitis

Laquinimod effectively inhibits development of EAU and its associated immune effector responses

Non-redundant requirement for CXCR3 signaling for effective treatment of eye-specific autoimmunity with type I IFNs

Interferon beta modulates immune-mediated retinal inflammation by impairing T-cell trafficking

Chronic, Systemic Interleukin-18 Does Not Promote Macular Degeneration or Choroidal Neovascularization

Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal Degeneration

Th9-induced conjunctival inflammation: A new animal model for allergic conjunctivitis

TMP778 Inhibits Induction of Experimental Autoimmune Uveitis and related immune responses

Inflammasomes Induced by 7-Ketocholesterol and Other Stimuli in RPE and in Bone Marrow–Derived Cells Differ Markedly in Their Production of IL-1β and IL-18

Leucine-rich repeat kinase 2 (LRRK2) deficiency diminishes the development of EAU

Effects of digoxin on experimental autoimmune uveitis (EAU) development and the mouse retina

ITE, A Novel Endogenous Nontoxic Aryl Hydrocarbon Receptor Ligand, Efficiently Suppresses EAU and T-Cell–Mediated Immunity

7-Ketocholesterol Induces Interleukin(IL)-1 beta and IL-18 Production in RPE Cells via Activation of the Inflammasome

TL1A is a potent enhancer of IL-9 production and ocular immunopathogenicity by Th9 cells

A Novel Nontoxic Aryl Hydrocarbon Receptor Ligand, ITE, Suppresses Immune-mediated Ocular Inflammation

Cell-cell Interaction with APC, not IL-23, is Required for Naive CD4 Cells to Acquire Pathogenicity During Th17 Lineage Commitment

DAP-12, a Major Immunomediator, Either Promotes or Suppresses EAU Development

Acquisition of Th1, Th17, or Treg Phenotypes Differs Among CD4 T Cells in Ocular Inflammation Triggered by Different TLR Ligands

SLAT/Def6 Knock-Out (KO) Mice Exhibit Profoundly Reduced Capacity to Develop Experimental Autoimmune Uveitis (EAU)

Antigen-Specific Th9 Cells are Unique in their Cytokine Kinetics, Plasticity and Retention at the Inflammatory Site

To View More...

You must be signed into an individual account to use this feature.